Biogen's ALS Drug Won't Move Forward After Trial Failures
Biogen will stop developing a drug to treat a severe neurodegenerative disease, as it did not show sufficient benefit when tested in trials. Patients with amyotrophic lateral scler…
More from Mississippi Business
Mississippi Works
Mississippi's Pro-Business Tax Climate Strengthens Your Bottom Line
Mississippi Business
•
Aug 28, 2026
Mississippi Works
Mississippi's Reshoring Moment: Leveraging Local Strengths for Global Competitiveness
Mississippi Business
•
Jul 8, 2026
Mississippi Works
Median Household Income Continues Upward Trend
Mississippi Business
•
Apr 21, 2026
Sun Herald Business
Detroit Auto Show rebrands, releases schedule for January 2025 return
Mississippi Business
•
Jul 31, 2024
Sun Herald Business
Justi-cation? There is a new viral travel word going around
Mississippi Business
•
Jul 31, 2024
Sun Herald Business
Analysts update Southwest Airlines stock price target on revenue plan
Mississippi Business
•
Jul 31, 2024
Sun Herald Business
New Ford tech pushes the limits of driver privacy and surveillance
Mississippi Business
•
Jul 31, 2024